Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from ...
The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not ...
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...
Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...
The National on MSN15h
Two years on, are GLP-1 drugs such as Ozempic and Mounjaro here to stay?In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...
RejuvenationMD offers popular semaglutide and CoolSculpting treatments to help clients gain confidence and feel better. Sponsored by RejuvenationMD.
Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...
Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback